A Role for SHIP in Stem Cell Biology and Transplantation

Author(s): William G. Kerr

Journal Name: Current Stem Cell Research & Therapy

Volume 3 , Issue 2 , 2008

Become EABM
Become Reviewer
Call for Editor


Inositol phospholipid signaling pathways have begun to emerge as important players in stem cell biology and bone marrow transplantation [1-4]. The SH2-containing Inositol Phosphatase (SHIP) is among the enzymes that can modify endogenous mammalian phosphoinositides. SHIP encodes an isoform specific to pluripotent stem (PS) cells [5,6] plays a role in hematopoietic stem (HS) cell biology [7,8] and allogeneic bone marrow (BM) transplantation [1,2,9,10]. Here I discuss our current understanding of the cell and molecular pathways that SHIP regulates that influence PS/HS cell biology and BM transplantation. Genetic models of SHIP-deficiency indicate this enzyme is a potential molecular target to enhance both autologous and allogeneic BM transplantation. Thus, strategies to reversibly target SHIP expression and their potential application to stem cell therapies and allogeneic BMT are also discussed.

Keywords: phosphorylation, microenvironment, antigen presenting cells, Natural Killer cells, transplantation

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Published on: 01 March, 2012
Page: [99 - 106]
Pages: 8
DOI: 10.2174/157488808784223050

Article Metrics

PDF: 31